5f23fe6d-figure-01 (5f23fe6d Figure 01)
Metoprolol Succinate Tablet, Extended Release
Product Images NDC 75834-291
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 75834-291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
1 (5f23fe6d Figure 02)
3 (Mts25 1000ct)
This is a medication description for Metoprolol Succinate tablets containing 23.75 mg of active ingredient equivalent to 25 mg of Metoprolol Tartrate, USP intended for prescription use only as per accompanying package instructions. The pills should be stored at a temperature range of 20°C to 25°C with permitted excursions between 15°C to 30°C. The medication should be kept out of children's reach. The tablets are manufactured for Nivagen Pharmaceuticals, Inc. in Sacramento, California, and dispensed in a tight, light-resistant container, per USP regulations. The provided NDC number is 75834-290-00. The description suggests that the package comes with 1000 tablets.*
1 (Mts25 100ct)
This is a medication containing Metoprolol Succinate (extended-release) in the form of tablets. The tablets have 23.75 mg of Metoprolol Succinate, which is equivalent to 25 mg of Metoprolol Tartrate, USR. It is recommended to use as per the information provided on the package insert or the doctor's prescription. The tablets come in a light-resistant container and the storage temperature should be between 20 to 25°C. It is also advised to keep them out of the reach of children. These tablets are manufactured by Nivagen Pharmaceuticals, Inc. located in Sacramento, CA.*
2 (Mts25 500ct)
This is a description of a medication called Metoprolol Succinate, which comes in tablet form. Each tablet contains 23.75 mg of Metoprolol Succinate equivalent to 25 mg Metoprolol Tartrate, USR. The usual dosage information can be found in the accompanying package insert. It is an extended-release medication that should be stored at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F), in a tight, light-resistant container. The medication should be kept out of the reach of children, and it is available only through a prescription (Rx only). The manufacturer of this medication is Nivagen Pharmaceuticals, Inc. located in Sacramento, CA, USA. However, there might be additional important information in the accompanying package insert, which is not included in this text.*
6 (Mts50 1000ct)
This is a medication with two active ingredients, Metoprolol Succinate and Metoprolol Tartrate USR. Each tablet contains 47.5mg of Metoprolol Succinate equivalent to Me to p ro Io I s ucc inate and 50mg Metoprolol Tartrate, USR. The usual recommended dosage is included in the package insert. It is essential to store the tablets at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The medication should be dispensed in a tight, light-resistant container, and it's warning declares that it should be kept out of reach of children. The manufacturer is Nivagen Pharmaceuticals Inc. located in Sacramento, CA, and it is their toll-free number.*
4 (Mts50 100ct)
This is a description of a medication called Metoprolol Succinate Extended-Release Tablets USP with a strength of 47.5mg, equivalent to 50mg Metoprolol Tartrate. It includes information on dosage, storage temperature, and manufacturer. The medication should be kept out of reach of children and dispensed in a tightly sealed container. The NDC code for the tablets is 75834-291-01. The document was last reviewed in December 2021.*
5 (Mts50 500ct)
Each tablet contains 47.5 mg of Metoprolol Succinate equivalent to 50 mg Metoprolol Tartrate USR. The usual dosage information is available in the package insert. It is recommended to store the tablets at 20° to 25°C and dispense in a tight, light-resistant container. The medication should be kept away from the reach of children. The tablets are manufactured by Nivagen Pharmaceuticals, Inc. A toll-free number is provided for inquiries. NDC code is 75834-291-05. This medication is available by prescription only.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
